by pepidwpblog | Nov 5, 2018 | Press & Media
For Immediate Release: September 15, 2017 — Phoenix, AZ Statement: PEPID, LLC, the leading developer of point-of-care clinical decision support solutions, will be participating in the ASHP Midyear 2018 Clinical Meeting and Exhibition as an exhibitor at booth...
by PEPID Newsroom | Nov 2, 2018 | Alerts
Yesterday, November 1st, the federal Centers for Medicare & Medicaid Services (CMS) published their final rule for the Physician Fee Schedule for CY 2019, and Quality Payment Program (QPP)—regarding the Patients Over Paperwork Initiative, E&M requirements,...
by PEPID Newsroom | Nov 1, 2018 | Alerts
23andMe is the first direct-to-consumer (DTC) genetic test to be permitted by the FDA to market their pharmacogenomic reports providing information regarding genetic variants that may be associated with a patient’s ability to metabolize some medications to help inform...
by Anna Tan | Nov 1, 2018 | Pharmacy
Moving Forward with New Provisions The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), signed on October 24, 2018, addresses the opioid crisis by reducing supply and access while...
by PEPID Newsroom | Oct 31, 2018 | Alerts
Yesterday the U.S. Food and Drug Administration approved Xofluza (balorxavir marhboxil), a new influenza treatment for acute uncomplicated influenza in people age 12 and older who have been symptomatic for no more than 2 days. This new drug, developed by Genentech,...
by PEPID Newsroom | Oct 22, 2018 | Alerts
The CDC is baffled by the cause of polio-like disease, Acute Flaccid Myelitis (AFM), affecting children in the United States. A reoccurring outbreak of AFM has been affecting Americans 21 and under since 2014. The CDC has recorded spikes in cases of Acute Flaccid...
by PEPID Newsroom | Oct 22, 2018 | Alerts
Toxic dinoflagellates algal blooms known as “red tides” are spreading across the Florida coastline, killing thousands of marine animals, and causing respiratory and gastrointestinal distress in residents. People in effected areas are warned not to swim in the water,...
by Anna Tan | Oct 17, 2018 | Press & Media
For Immediate Release: October 17, 2018 — Phoenix, AZ STATEMENT: Web-based point-of-care solutions provider, PEPID, LLC, released a new feature on their IV Compatibility Checker that adds an extra layer of assurance to, not only safe, but effective IV drug...
by Anna Tan | Oct 15, 2018 | Pharmacy, Primary Care
Getting a Bigger Slice of the P.I.E.: The Pharmacist’s Duties in Clinical Pharmacogenomics (PGx) Ninety percent of Americans live within 5 miles of a community pharmacy, with local patients averaging 35 drugstore visits annually. Compared to the average frequency of 4...
by Anna Tan | Oct 8, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Pharmacogenomics (PGx) is rapidly evolving from being a “luxury” diagnostic test to the healthcare standard millions of patients and providers have been waiting for. Although PGx is a relatively new field, the R&D support and buzz behind it is growing...
